Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela J Maxwell

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Molecular Cancer Research : MCR|July 4, 2007
Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cellsChristopher F MacManus, Johanna Pettigrew, Angela Seaton, et al.
European Urology|September 4, 2012
Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinomaPamela J Maxwell, Jonathan Coulter, Steven M Walker, et al.
Cancer Research|May 1, 2002
The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolatesDaniel B Longley, John Boyer, Wendy L Allen, et al.
Cell Death & Disease|October 24, 2018
Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonistsChristopher McCann, Nyree Crawford, Joanna Majkut, et al.
Molecular Cancer Research : MCR|March 18, 2022
Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate CancersPamela J Maxwell, Melanie McKechnie, Christopher W Armstrong, et al.
Oncotarget|January 23, 2016
PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapyChris W D Armstrong, Pamela J Maxwell, Chee Wee Ong, et al.
NAR Cancer|August 4, 2020
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinomaChris W D Armstrong, Jonathan A Coulter, Chee Wee Ong, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molecular Cancer Research : MCR|July 4, 2007
Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cellsChristopher F MacManus, Johanna Pettigrew, Angela Seaton, et al.
European Urology|September 4, 2012
Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinomaPamela J Maxwell, Jonathan Coulter, Steven M Walker, et al.
Cancer Research|May 1, 2002
The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolatesDaniel B Longley, John Boyer, Wendy L Allen, et al.
Cell Death & Disease|October 24, 2018
Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonistsChristopher McCann, Nyree Crawford, Joanna Majkut, et al.
Molecular Cancer Research : MCR|March 18, 2022
Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate CancersPamela J Maxwell, Melanie McKechnie, Christopher W Armstrong, et al.
Oncotarget|January 23, 2016
PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapyChris W D Armstrong, Pamela J Maxwell, Chee Wee Ong, et al.
NAR Cancer|August 4, 2020
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinomaChris W D Armstrong, Jonathan A Coulter, Chee Wee Ong, et al.
Pageof 2